MetaCap

SIGA Technologies (SIGA) vs Whitehawk Therapeutics (WHWK)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Whitehawk Therapeutics (WHWK) has outperformed SIGA Technologies (SIGA) over the past year, gaining 45.5% versus a loss of 58.9%. Over five years, SIGA leads with a -71.9% price change compared with -86.4% for WHWK. Whitehawk Therapeutics is the larger company by market cap ($181.2 million vs $172.5 million), about 1.1 times the size, while SIGA Technologies is growing revenue faster (-31.8% vs -72.5%).

SIGA Technologies converts more of its revenue into profit, with a net margin of 24.6% versus -288.3%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

SIGA-58.90%WHWK+45.50%
+152%+41%-69%
Nov 21, 20251 yearNov 20, 2026
SIGA-74.08%WHWK-87.61%
+180%+36%-108%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

SIGA versus WHWK key metrics
MetricSIGAWHWK
Share price$2.40$3.07
Market cap$172.45M$181.16M
1-day change-9.43%-1.60%
YTD return-60.72%+26.86%
1-year return-58.90%+45.50%
5-year return-71.90%-86.36%
P/E ratio (TTM)240.00—
Forward P/E5.45—
EPS (TTM)$0.01$-1.10
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$94.57M$7.14M
Revenue growth (YoY)-31.82%-72.50%
Net income (latest FY)$23.28M$-20.60M
Gross margin68.59%89.36%
Operating margin25.06%-1601.12%
Net margin24.61%-288.26%
52-week high$7.11$5.50
52-week low$2.30$2.10
Distance from 52-week high-66.24%-44.13%
Analyst consensusstrong_buybuy
Avg. price target upside+35.42%+151.14%
Average volume617.60K348.68K
Shares outstanding71.86M59.01M
Employees4937
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • WHWK has outperformed SIGA by 104.4 percentage points over the past year.
  • SIGA Technologies is more profitable, keeping 24.6 cents of every revenue dollar as net income versus -288.3 cents for Whitehawk Therapeutics.
  • SIGA Technologies grew revenue faster in its latest fiscal year (-31.82% vs -72.50%).

About SIGA Technologies

SIGA stock →

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus.

Health Care · Biotechnology: Pharmaceutical Preparations · 49 employees

About Whitehawk Therapeutics

WHWK stock →

Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer.

Health Care · Biotechnology: Pharmaceutical Preparations · 37 employees

SIGA vs WHWK FAQ

Which is bigger, SIGA Technologies or Whitehawk Therapeutics?

Whitehawk Therapeutics (WHWK) is larger, with a market capitalization of $181.16M compared with $172.45M for SIGA Technologies (SIGA).

Which stock has performed better over the past year, SIGA or WHWK?

WHWK returned +45.50% over the past 12 months, compared with -58.90% for SIGA (price return, excluding dividends). Past performance does not predict future results.

Are SIGA Technologies and Whitehawk Therapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons